Pfizer (PFE) Construction in Progress (2009 - 2013)

Pfizer has disclosed Construction in Progress across 5 years of filings, most recently posting $1.1 billion for Q4 2013.

• In Q4 2013, Construction in Progress rose 15.15% year-over-year to $1.1 billion; the TTM figure through Dec 2013 stood at $1.1 billion (up 15.15% YoY), while the FY2013 annual figure was $1.1 billion, up 15.15% from the prior year.
• Construction in Progress improved to $1.1 billion in Q4 2013, from $957.0 million in the prior quarter.
• Over the last five years, Construction in Progress for PFE reached as high as $2.0 billion in Q4 2009 and fell as low as $957.0 million in Q4 2012.
• The 5-year median for Construction in Progress is $1.1 billion (2013), against an average of $1.3 billion.
• Annual changes were most pronounced in 2010 — Construction in Progress tumbled 49.19% — and 2011, when it rose 29.53%.
• A 5-year view of Construction in Progress shows it stood at $2.0 billion in 2009, then tumbled by 49.19% to $999.0 million in 2010, then rose by 29.53% to $1.3 billion in 2011, then decreased by 26.04% to $957.0 million in 2012, then rose by 15.15% to $1.1 billion in 2013.
• According to Business Quant data, Construction in Progress over the past three periods registered $1.1 billion, $957.0 million, and $1.3 billion for Q4 2013, Q4 2012, and Q4 2011 respectively.